SLCO5A1: A Potential Drug Target for Neuronal Ion Transport and Pain Regulation

Target Name: SLCO5A1

NCBI ID: G81796

SLCO5A1

SLCO5A1: A Potential Drug Target for Neuronal Ion Transport and Pain Regulation

SLCO5A1 (also known as FLJ39560) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the sodium-dependent chloride transport system (SLC) family, which is responsible for transporting chloride ions into and out of cells.

SLCO5A1 has been identified as a potential drug target due to its role in the regulation of ion transport and its expression in various tissues. Studies have shown that alterations in SLCO5A1 levels or activity can affect the transport of chloride ions, which can have a significant impact on cellular processes such as ion homeostasis, neurotransmitter release, and ultimately, the function of the organism.

One of the key features of SLCO5A1 is its role in maintaining the resting membrane potential of neurons. The membrane potential of a neuron is the potential difference between the positive and negative charges on the membrane, and it is critical for the efficient transmission of electrical signals. SLCO5A1 helps to maintain the stability of the membrane potential by regulating the movement of chloride ions into and out of the cell.

In addition to its role in maintaining the membrane potential, SLCO5A1 is also involved in the regulation of neurotransmitter release. When a neuron is excited, it sends a neurotransmitter signal along its axon to other neurons. The release of neurotransmitters is regulated by the voltage-dependent ion channels (VDCC) on the surface of the neuron, and SLCO5A1 is involved in the regulation of these channels.

SLCO5A1 has also been shown to be involved in the regulation of pain perception. Chronic pain is a complex condition that is often associated with inflammation and neurotransmitter release. SLCO5A1 has been shown to play a role in the regulation of neurotransmitter release from neurons, which may contribute to the development and maintenance of chronic pain.

In conclusion, SLCO5A1 is a protein that has been identified as a potential drug target due to its role in the regulation of ion transport and its expression in various tissues. Further research is needed to fully understand the mechanisms of SLCO5A1 and its potential as a drug target.

Protein Name: Solute Carrier Organic Anion Transporter Family Member 5A1

The "SLCO5A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLCO5A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets